Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report

被引:7
作者
Ponti, Giovanni [1 ,6 ]
Pollio, Annamaria [2 ]
Pastorino, Lorenza [3 ]
Pellacani, Giovanni [1 ]
Magnoni, Cristina [1 ]
Nasti, Sabina [3 ]
Fortuna, Giulio [2 ,4 ]
Tomasi, Aldo [6 ]
Scarra, Giovanna Bianchi [3 ,5 ]
Seidenari, Stefania [1 ]
机构
[1] Univ Modena & Reggio Emilia, Div Dermatol, Dept Head & Neck Surg, I-41100 Modena, Italy
[2] Univ Naples Federico II, Sch Med & Surg, Oral Med Unit, Dept Odontostomatol & Maxillofacial Sci, Naples, Italy
[3] Univ Hosp Genoa, Mol Genet Unit, Genoa, Italy
[4] Stanford Univ, Dept Dermatol, Sch Med, Ctr Clin Sci Res, Stanford, CA 94305 USA
[5] Osped San Martino Genova, Lab Rare Hereditary Canc, Genoa, Italy
[6] Univ Modena & Reggio Emilia, Dept Lab Pathol Anat & Forens Med, I-41100 Modena, Italy
关键词
nevoid basal cell carcinoma syndrome; PTCH1; odontogenic keratocysts; Gorlin syndrome; GERM-LINE MUTATIONS; SONIC HEDGEHOG; PTCH GENE; GORLIN-SYNDROME; NEVUS SYNDROME; PHENOTYPE; FAMILIES; GROWTH; REGION;
D O I
10.3892/ol.2012.707
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in the Patched homolog I (PTCH1) gene lead to an autosomal dominant disorder known as nevoid basal cell carcinoma syndrome (NBCCS) or Gorlin syndrome (GS). Several PTCH1 mutations have been observed in NBCCS associated with keratocystic odontogenic tumors (KCOTs), including non-syndromic KCOTs. The missense mutation c.3277G>C (p.G1093R) in exon 19 of the PTCH1 gene has only been reported in non-syndromic KCOTs. The present study reports for the first time a familial case (father and daughter) of NBCCS and KCOTs, carrying the same c.3277G>C (p.G1093R) germline mutation. This observation suggests that this missense mutation is involved in the pathogenesis of NBCCS as well as in a subset of non-syndromic KCOTs. The identification of a missense mutation may lead to an earlier diagnosis of NBCCS.
引用
收藏
页码:241 / 244
页数:4
相关论文
共 32 条
[1]  
ANDERSON DE, 1967, AM J HUM GENET, V19, P12
[2]  
Barreto DC, 2000, J DENT RES, V79, P1418, DOI 10.1177/00220345000790061101
[3]   Predictors of the risk of mortality in neurofibromatosis 2 [J].
Baser, ME ;
Friedman, JM ;
Aeschliman, D ;
Joe, H ;
Wallace, AJ ;
Ramsden, RT ;
Evans, DGR .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) :715-723
[4]   Spectrum of PTCH1 mutations in French patients with Gorlin syndrome [J].
Boutet, N ;
Bignon, YJ ;
Drouin-Garraud, V ;
Sarda, P ;
Longy, M ;
Lacombe, D ;
Gorry, P .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (03) :478-481
[5]  
Dassule HR, 2000, DEVELOPMENT, V127, P4775
[6]  
DAVIES DR, 1995, AM J HUM GENET, V57, P1151
[7]  
Diniz MG, 2009, ORAL ONCOL, V45, P291, DOI 10.1016/j.oraloncology.2008.05.020
[8]   Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E [J].
Duman-Scheel, M ;
Weng, L ;
Xin, SJ ;
Du, W .
NATURE, 2002, 417 (6886) :299-304
[9]   COMPLICATIONS OF THE NEVOID BASAL-CELL CARCINOMA SYNDROME - RESULTS OF A POPULATION-BASED STUDY [J].
EVANS, DGR ;
LADUSANS, EJ ;
RIMMER, S ;
BURNELL, LD ;
THAKKER, N ;
FARNDON, PA .
JOURNAL OF MEDICAL GENETICS, 1993, 30 (06) :460-464
[10]   Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations [J].
Evans, DGR ;
Trueman, L ;
Wallace, A ;
Collins, S ;
Strachan, T .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (06) :450-455